These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 27238222)

  • 21. Superiority of DAT over ELISA as a diagnostic and seroepidemiological tool for the diagnosis of Indian Kala-azar.
    Goyal RK; Mohapatra TM
    Indian J Med Microbiol; 2004; 22(1):57-60. PubMed ID: 17642689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of surfactants on penetration across the skin*.
    Walters KA; Bialik W; Brain KR
    Int J Cosmet Sci; 1993 Dec; 15(6):260-71. PubMed ID: 19281616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Kala-azar; clinical and physiopathological study a propos of a new case studied in Switzerland].
    Pugin P; Miescher PA
    Schweiz Med Wochenschr; 1979 Feb; 109(8):265-9. PubMed ID: 219473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum.
    Karp CL; Turco SJ; Sacks DL
    J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India.
    Thakur CP; Kumar A; Mitra G; Thakur S; Sinha PK; Das P; Bhattacharya SK; Sinha A
    Indian J Med Res; 2008 Jul; 128(1):38-44. PubMed ID: 18820357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Les enzymes de l'espace extra-cellulaire du stratum corneum.
    Forestier JP
    Int J Cosmet Sci; 1992 Apr; 14(2):47-63. PubMed ID: 19272098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First impression versus extended usage: a comparison of product testing methodologies for perfume.
    Shalofsky I
    Int J Cosmet Sci; 1993 Apr; 15(2):63-75. PubMed ID: 19272121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A propos de l'obésité chez le chien.
    Brown RG
    Can Vet J; 1990 Jan; 31(1):46-9. PubMed ID: 17423500
    [No Abstract]   [Full Text] [Related]  

  • 31. [Flavonoids of Artemisia campestris, ssp. glutinosa].
    Hurabielle M; Eberle J; Paris M
    Planta Med; 1982 Oct; 46(2):124-5. PubMed ID: 17396957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
    Shah H
    JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kala-azar as an AIDS-related opportunistic infection.
    Murray HW
    AIDS Patient Care STDS; 1999 Aug; 13(8):459-65. PubMed ID: 10800524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M; Majumder HK; Sundar S; Bhaduri AN
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for Indian kala-azar.
    Ranjan A; Sur D; Singh VP; Siddique NA; Manna B; Lal CS; Sinha PK; Kishore K; Bhattacharya SK
    Am J Trop Med Hyg; 2005 Jul; 73(1):74-8. PubMed ID: 16014837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Present situation of vector-control management in Bangladesh: a wake up call.
    Mondal D; Alam MS; Karim Z; Haque R; Boelaert M; Kroeger A
    Health Policy; 2008 Sep; 87(3):369-76. PubMed ID: 18342389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Awareness about kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India.
    Siddiqui NA; Kumar N; Ranjan A; Pandey K; Das VN; Verma RB; Das P
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):1-12. PubMed ID: 20578475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
    Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
    Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.